Literature DB >> 10371504

The intrinsic factor-vitamin B12 receptor, cubilin, is a high-affinity apolipoprotein A-I receptor facilitating endocytosis of high-density lipoprotein.

R Kozyraki1, J Fyfe, M Kristiansen, C Gerdes, C Jacobsen, S Cui, E I Christensen, M Aminoff, A de la Chapelle, R Krahe, P J Verroust, S K Moestrup.   

Abstract

Cubilin is the intestinal receptor for the endocytosis of intrinsic factor-vitamin B12. However, several lines of evidence, including a high expression in kidney and yolk sac, indicate it may have additional functions. We isolated apolipoprotein A-I (apoA-I), the main protein of high-density lipoprotein (HDL), using cubilin affinity chromatography. Surface plasmon resonance analysis demonstrated a high-affinity binding of apoA-I and HDL to cubilin, and cubilin-expressing yolk sac cells showed efficient 125I-HDL endocytosis that could be inhibited by IgG antibodies against apoA-I and cubilin. The physiological relevance of the cubilin-apoA-I interaction was further emphasized by urinary apoA-I loss in some known cases of functional cubilin deficiency. Therefore, cubilin is a receptor in epithelial apoA-I/HDL metabolism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10371504     DOI: 10.1038/9504

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  63 in total

Review 1.  Molecular regulation of HDL metabolism and function: implications for novel therapies.

Authors:  Daniel J Rader
Journal:  J Clin Invest       Date:  2006-12       Impact factor: 14.808

Review 2.  Role of apolipoproteins in gammadelta and NKT cell-mediated innate immunity.

Authors:  Eric Champagne; Laurent O Martinez; Pierre Vantourout; Xavier Collet; Ronald Barbaras
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

Review 3.  Receptor-mediated endocytosis in renal proximal tubule.

Authors:  Erik Ilsø Christensen; Pierre J Verroust; Rikke Nielsen
Journal:  Pflugers Arch       Date:  2009-06-05       Impact factor: 3.657

4.  Lower HDL-C and apolipoprotein A-I are related to higher glomerular filtration rate in subjects without kidney disease.

Authors:  Jan A Krikken; Ron T Gansevoort; Robin P F Dullaart
Journal:  J Lipid Res       Date:  2010-03-08       Impact factor: 5.922

5.  CUB-domain-containing protein 1 (CDCP1) activates Src to promote melanoma metastasis.

Authors:  Hui Liu; Shao-En Ong; Kwabena Badu-Nkansah; Jeffrey Schindler; Forest M White; Richard O Hynes
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

Review 6.  Residual Cardiovascular Risk in Chronic Kidney Disease: Role of High-density Lipoprotein.

Authors:  Valentina Kon; Haichun Yang; Sergio Fazio
Journal:  Arch Med Res       Date:  2015-05-23       Impact factor: 2.235

7.  Regulation of apoAI processing by procollagen C-proteinase enhancer-2 and bone morphogenetic protein-1.

Authors:  Jian Zhu; Joseph Gardner; Clive R Pullinger; John P Kane; John F Thompson; Omar L Francone
Journal:  J Lipid Res       Date:  2009-02-23       Impact factor: 5.922

8.  Megalin-dependent cubilin-mediated endocytosis is a major pathway for the apical uptake of transferrin in polarized epithelia.

Authors:  R Kozyraki; J Fyfe; P J Verroust; C Jacobsen; A Dautry-Varsat; J Gburek; T E Willnow; E I Christensen; S K Moestrup
Journal:  Proc Natl Acad Sci U S A       Date:  2001-10-16       Impact factor: 11.205

9.  AMN directs endocytosis of the intrinsic factor-vitamin B(12) receptor cubam by engaging ARH or Dab2.

Authors:  Gitte Albinus Pedersen; Souvik Chakraborty; Amie L Steinhauser; Linton M Traub; Mette Madsen
Journal:  Traffic       Date:  2010-01-18       Impact factor: 6.215

10.  A pivotal role of the human kidney in catabolism of HDL protein components apolipoprotein A-I and A-IV but not of A-II.

Authors:  Jonas Heilskov Graversen; Graciela Castro; Abdelmejid Kandoussi; Henning Nielsen; Erik Ilsø Christensen; Anthony Norden; Søren Kragh Moestrup
Journal:  Lipids       Date:  2008-03-19       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.